Skip to main content
Veeva Systems Inc (VEEV)
Computer Software and Services Information Technology
Stock AI

Veeva Systems Launches Veeva CRM Pulse: A Game-Changer for HCP Data Access

Last updated: March 04, 2025
Taurigo

Location: Pleasanton, California

Veeva Systems Inc. (NYSE: VEEV) has announced a significant advancement in healthcare professional (HCP) data management with the launch of Veeva CRM Pulse, a new data subscription service designed for the life sciences industry. This innovative product aims to enhance segmentation and targeting strategies for commercial operations and data analytics teams by providing detailed access and engagement metrics across 21 countries.

1. Transforming HCP Engagement

Veeva CRM Pulse is set to reshape how life sciences companies interact with healthcare professionals by offering quarterly access data that allows for more precise segmentation and improved engagement planning. The service is designed to deliver immediate value, streamlining operations for teams that rely on accurate data to inform their strategies.

Unique Features of Veeva CRM Pulse

Veeva CRM Pulse stands out in the crowded market of HCP data solutions due to its:

  • True Industry Census: Pulse boasts a comprehensive dataset based on the extensive global use of Veeva's leading CRM Suite, ensuring that the information is not only complete but also timely and accurate.
  • Unmatched Coverage: The service provides access and engagement metrics for over three million HCPs, covering 102 specialties across 21 countries, thereby offering unparalleled insights into the healthcare landscape.
  • Data Privacy Assurance: All metrics are aggregated and segmented by country, specialty, and brick, ensuring compliance with data privacy regulations while still delivering valuable insights.

2. Executive Insights

Peter Stark, Executive Vice President of Veeva Data Cloud, emphasized the transformative potential of Veeva CRM Pulse for life sciences companies: "Pulse is a breakthrough data product that will greatly improve segmentation and targeting around the globe. We look forward to working with our early customers to bring the value of CRM Pulse data to their commercial operations."

3. Availability and Future Expansion

Veeva CRM Pulse is now available for license to Veeva's CRM customers, with the initial release offering quarterly data from 2024. This includes comprehensive metrics for key markets such as the United States, Canada, Germany, the United Kingdom, and several others. As the service evolves, quarterly data releases for 2025 are set to commence in April, with plans to expand into additional countries in Asia and Europe in the following year.

4. Part of a Broader Data Ecosystem

Veeva CRM Pulse is an integral part of the Veeva Data Cloud, which includes existing products like Veeva OpenData, Veeva Link, and Veeva Compass. By integrating these solutions, Veeva is positioning itself as a leader in providing actionable insights to the life sciences sector, aiding companies in making informed decisions based on robust data.

5. About Veeva Systems

Veeva Systems is recognized as the global leader in cloud software tailored for the life sciences industry. Serving over 1,000 customers, from major biopharmaceutical companies to emerging biotech firms, Veeva is dedicated to innovation, product excellence, and customer success. As a Public Benefit Corporation, Veeva aims to balance the interests of all stakeholders, ensuring a commitment to ethical practices within the industry.

For further information on Veeva CRM Pulse and other offerings from Veeva Systems, visit veeva.com/eu/Pulse.

In conclusion, with the launch of Veeva CRM Pulse, Veeva Systems is not just enhancing its product portfolio but is also setting a new standard for HCP engagement, making it an essential tool for life sciences companies aiming to optimize their commercial operations in a rapidly evolving market.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.